Patents Assigned to Elicio Therapeutics, Inc.
  • ALK polypeptides and methods of use thereof
    Patent number: 11623002
    Abstract: The invention features immunogenic compositions containing anaplastic lymphoma kinase (ALK) polypeptides and methods of use thereof. The immunogenic compositions and methods of the invention may be used to treat a disease associated with ALK in a subject, such as cancer (e.g., a solid tumor cancer or an ALK+ cancer).
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: April 11, 2023
    Assignee: Elicio Therapeutics, Inc.
    Inventors: Adrienne Li, Jackson Eby, Peter C. Demuth